Zimmer Biomet Holdings (ZBH) Payables (2009 - 2026)

Zimmer Biomet Holdings has reported Payables for 18 years, with the latest figure at $352.4 million in Q2 2026.

• On a quarterly basis, Payables rose 1.06% year-over-year to $352.4 million in Q2 2026; TTM through Jun 2026 was $352.4 million, a 1.06% increase from a year earlier, with the FY2025 full-year figure at $303.0 million, up 55.7% from the prior year.
• Payables was $352.4 million for Q2 2026 at Zimmer Biomet Holdings, down from $361.2 million in the prior quarter.
• The five-year high for Payables was $437.1 million in Q4 2022, with the low at $194.6 million in Q4 2024.
• Average Payables over 5 years is $338.5 million, with a median of $337.8 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Payables tumbled 52.61% in 2024, then jumped 55.7% in 2025.
• Over 5 years, Payables stood at $437.1 million in 2022, then declined by 6.06% to $410.6 million in 2023, then sank by 52.61% to $194.6 million in 2024, then jumped by 55.7% to $303.0 million in 2025, then increased by 16.3% to $352.4 million in 2026.
• The last three Payables figures came in at $352.4 million (Q2 2026), $361.2 million (Q1 2026), and $303.0 million (Q4 2025), per Business Quant data.